Prof Collen Masimirembwa was awarded (HUGO)
Prof Collen Masimirembwa was awarded the Human Genome Organization (HUGO) Award for Africa for 2018. The Award was present at the Human Genome Meeting 2018 (March 12-15) in Yokohama, Japan. This is given to a researcher who has performed extraordinary work in biomedical sciences which has changed the thinking in the field where important technology was developed; or who has uncovered new insight which brought new therapies, or whose lifetime contribution has significantly impact the African region and who is primary affiliation in Africa.
Professor Masimirembwa has made extraordinary contributions to understanding the genomic diversity of African populations and its importance to medicine. Through this work he has discovered genetic variants unique to African populations that could explain why they might respond differently to some medicines with respect to safety and efficacy. He has developed a pharmacogentic test and dosing algorithms, GeneDose-Efavirenz, for the safe use of the antiretroviral drug, Efavirenz, in African populations. This innovative product is now being developed for commercialization and represents the first such test to be developed and deployed on the African continent.